- Home
- BDRX vs EDVA Comparison
BDRX vs EDVA Comparison
Compare BDRX & EDVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDRX | EDVA |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United Kingdom | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6M | 1.9M |
| IPO Year | 2015 | 2012 |
Fundamental Metrics
Financial Performance| Metric | BDRX | EDVA |
|---|---|---|
| Price | $1.30 | $0.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 263.0K | 180.2K |
| Earning Date | 09-12-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.30 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $73,066.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.60 | $0.23 |
| 52 Week High | $11.88 | $0.32 |
Technical Indicators
Market Signals| Indicator | BDRX | EDVA |
|---|---|---|
| Relative Strength Index (RSI) | 19.77 | 2.92 |
| Support Level | $0.60 | N/A |
| Resistance Level | $1.50 | N/A |
| Average True Range (ATR) | 0.11 | 0.03 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 7.22 | 13.14 |
Price Performance
Historical ComparisonAbout BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About EDVA Endovia Health Sciences Inc. Common Stock
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.